LINC vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

LINC

50.6
AI Score
VS
UTI Wins

UTI

53.0
AI Score

Investment Advisor Scores

LINC

51score
Recommendation
HOLD

UTI

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LINC UTI Winner
Forward P/E 54.9451 47.1698 UTI
PEG Ratio 3.6658 3.1448 UTI
Revenue Growth 22.5% 6.7% LINC
Earnings Growth 133.2% -96.3% LINC
Tradestie Score 50.6/100 53.0/100 UTI
Profit Margin 4.1% 4.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

LINC 1M: -20.5% · 3M: +1.7% UTI 1M: -16.4% · 3M: +4.7%

Current Technical Phase

LINC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 39.1 · Price: $41.82

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $39.31

Fundamentals Snapshot

Metric LINC UTI
Market Cap
Forward P/E 38.7 46.2
Trailing P/E 58.3 54.1
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.72 0.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.